{"database": "openregs", "table": "documents", "rows": [["FDA-2014-D-1856-0061", "FDA", "FDA-2014-D-1856", "Human Cells, Tissues, and Cellular and Tissue-Based Products From \nAdipose Tissue: Regulatory Considerations; Draft Guidance for Industry; \nReopening of the Comment Period", "Proposed Rule", "Reopening of Comment Period", "2015-10-30T04:00:00Z", 2015, 10, "2015-10-30T04:00:00Z", "2016-04-30T03:59:59Z", "2024-11-07T23:24:13Z", "2015-27706", 1, 0, "0900006481cfc915"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2014-D-1856-0061"], "units": {}, "query_ms": 0.4951269365847111, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}